Oral itraconazole therapy for pityriasis versicolor
العنوان: | Oral itraconazole therapy for pityriasis versicolor |
---|---|
المؤلفون: | Alexandra Monastirli, D. Tsambaos, Efi Pasmatzi, C. Zografakis, S. Georgiou |
المصدر: | Journal of the European Academy of Dermatology and Venereology. 8:203-207 |
بيانات النشر: | Wiley, 1997. |
سنة النشر: | 1997 |
مصطلحات موضوعية: | medicine.medical_specialty, Itraconazole, Nausea, business.industry, Complete remission, Dermatology, Pityriasis, medicine.disease, Infectious Diseases, Pityrosporum ovale, medicine, medicine.symptom, Open label, business, Mycosis, medicine.drug |
الوصف: | The therapeutic efficacy and safety of oral itraconazole (200 mg/day for 7 days) was assessed in an open trial in 50 patients with pityriasis versicolor. At the end of the 1-week therapy complete remission and marked improvement were observed in 44% and 48% of the treated patients, respectively; 8% of the patients who showed no response were treated for 1 more week and also revealed a complete remission by the end of the 3-week follow-up ( 50 50 ). Headache and/or nausea occurred in 6% of the patients, whereas, the haematological and biochemical investigations revealed no abnormalities. The results of the present study clearly indicate that oral itraconazole is a highly efficacious and safe treatment for pityriasis versicolor. |
تدمد: | 1468-3083 0926-9959 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::86e4710f03bcb29777038d678d02b975 https://doi.org/10.1111/j.1468-3083.1997.tb00479.x |
حقوق: | CLOSED |
رقم الأكسشن: | edsair.doi...........86e4710f03bcb29777038d678d02b975 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 14683083 09269959 |
---|